These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 16977280

  • 1. A human papillomavirus vaccine.
    Med Lett Drugs Ther; ; 48(1241-1242):65-6. PubMed ID: 16977280
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.
    Garland SM, Steben M, Sings HL, James M, Lu S, Railkar R, Barr E, Haupt RM, Joura EA.
    J Infect Dis; 2009 Mar 15; 199(6):805-14. PubMed ID: 19199546
    [Abstract] [Full Text] [Related]

  • 5. The quadrivalent human papillomavirus vaccine.
    Wheat A.
    Med Health R I; 2008 Dec 15; 91(12):387-9. PubMed ID: 19170317
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Technology evaluation: HPV vaccine (quadrivalent), Aventis Pasteur MSD/CSL.
    Reinis M.
    Curr Opin Mol Ther; 2004 Apr 15; 6(2):206-11. PubMed ID: 15195933
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gardasil: Introducing the new human papillomavirus vaccine.
    McLemore MR.
    Clin J Oncol Nurs; 2006 Oct 15; 10(5):559-60. PubMed ID: 17063609
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. GARDASIL: prophylactic human papillomavirus vaccine development--from bench top to bed-side.
    Shi L, Sings HL, Bryan JT, Wang B, Wang Y, Mach H, Kosinski M, Washabaugh MW, Sitrin R, Barr E.
    Clin Pharmacol Ther; 2007 Feb 15; 81(2):259-64. PubMed ID: 17259949
    [Abstract] [Full Text] [Related]

  • 15. Quadrivalent human papillomavirus vaccine.
    Barr E, Tamms G.
    Clin Infect Dis; 2007 Sep 01; 45(5):609-7. PubMed ID: 17682997
    [Abstract] [Full Text] [Related]

  • 16. [Value of general human papillomavirus vaccination in sexually active women].
    Hampl M.
    Dtsch Med Wochenschr; 2009 Apr 01; 134 Suppl 2():S95-9. PubMed ID: 19353480
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Human papillomavirus quadrivalent vaccine: a look behind the numbers.
    Flaherty DK, Alkhateeb FM.
    Ann Pharmacother; 2009 Apr 01; 43(4):740-4. PubMed ID: 19276314
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus (HPV) vaccines: a Canadian update.
    Foerster V, Murtagh J.
    Issues Emerg Health Technol; 2007 Dec 01; (109):1-8. PubMed ID: 18062141
    [Abstract] [Full Text] [Related]

  • 20. Developing an HPV vaccine to prevent cervical cancer and genital warts.
    Bryan JT.
    Vaccine; 2007 Apr 20; 25(16):3001-6. PubMed ID: 17289220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.